The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate Cancer
NCT01545154 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17
Last updated 2014-03-28
Summary
This study is being done to find out if transperineal ultrasound (TPUS) can help define the prostate gland for radiation treatment planning and improve upon current methods of image guidance for the treatment of prostate cancer. For the patient, TPUS involves the placement of an ultrasound probe on the perineum, the skin between the scrotum and anus, while they are lying on their back in the position they will receive their treatment. Image-guidance is required for the treatment of prostate cancer because the prostate shifts position depending on how full the bladder and rectum are. Image-guided radiation therapy has been done at Fletcher Allen Health Care for approximately three years. Most commonly, transabdominal ultrasound images are obtained every day and compared to an ultrasound that was done on the day of treatment planning. Adjustments in radiation field position can be done on a daily basis by comparing these images. Transperineal ultrasound has never been used for image-guidance. The investigators completed an earlier study and have developed a TPUS device and process that allow us to get clear ultrasound pictures of the prostate gland. The TPUS has three potential advantages over the transabdominal method the investigators currently use:
1. Transabdominal ultrasound can be a challenge for some men. A full bladder helps us get clearer images, however it is difficult for some men with prostate cancer to comfortably keep a full bladder. It is also particularly difficult to get good images in larger men who have long distances from the skin surface to the prostate gland. TPUS is not dependent on a man having a full bladder and should be less dependent on the size of the man.
2. TPUS images and the planning CT images can be acquired simultaneously. This is not possible with the abdominal probe because it gets in the way of the CT machine. Simultaneous imaging eliminates the possibility of the prostate gland shifting positions during the time between imaging studies.
3. TPUS can be in place and acquire images during patient treatment (the abdominal probe gets in the way of the treatment machine) and may in the future allow us to watch the prostate gland during treatment. If the investigators discover that they can accurately view the prostate gland in real time, TPUS may ultimately allow us to treat even smaller radiation fields and possibly decrease the risk of radiation complications.
Patients in this study will be treated for their prostate cancer with the standard image guidance techniques used at Fletcher Allen Health Care: transabdominal ultrasound and/or X-ray imaging of gold marker seeds that have been placed the prostate gland. In addition to standard care, all men in this study will have TPUS and CT scans done a total of four times over 12 weeks to compare these methods of prostate localization over the course of radiation treatments. Some men may choose to take part in an additional study that will also include MRI of the pelvis to compare with the TPUS and CT. Because the prostate gland can be more clearly defined on MRI, some institutions (not Fletcher Allen) routinely have patients with prostate cancer get MRI scans for treatment planning. This has not been proven to improve the care of men with prostate cancer and it is possible that TPUS will provide similarly clear images. The potential advantages to TPUS imaging for prostate localization over MRI include the fact that it is done at the same time as the CT for treatment planning (so eliminates the possibility of movement of the prostate gland from the time of the MRI to the time of the CT) and can be done at a much lower cost.
Conditions
Interventions
- DEVICE
-
Transperineal Ultrasound
Sponsors & Collaborators
-
Elekta Limited
collaborator INDUSTRY -
H. James Wallace, MD
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- United States
Study Locations
More Related Trials
-
Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer
NCT06518226 ·Status: RECRUITING ·Phase: NA
-
Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer
NCT02766543 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PINPOINT Feasibility Study
NCT05481372 ·Status: UNKNOWN ·Phase: NA
-
Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer
NCT03814252 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
NCT04808427 ·Status: RECRUITING ·Phase: NA
-
Ion Prostate Irradiation
NCT01641185 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer
NCT01686958 ·Status: COMPLETED ·Phase: NA
-
Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer
NCT01352429 ·Status: ACTIVE_NOT_RECRUITING
-
Hypofractionated Whole Pelvic Radiotherapy of the Prostate
NCT02546427 ·Status: WITHDRAWN ·Phase: NA
-
Curative Image Guided Radiotherapy for Prostate Cancer
NCT01550237 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
NCT06542757 ·Status: RECRUITING ·Phase: NA
-
MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer
NCT01566045 ·Status: WITHDRAWN ·Phase: NA
-
Salvage Prostatectomy After Radiotherapy
NCT00791115 ·Status: COMPLETED ·Phase: NA
-
MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance
NCT02233725 ·Status: UNKNOWN ·Phase: PHASE1
-
Ablative Therapy in the Management of Prostate Cancer
NCT03492424 ·Status: RECRUITING
-
A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values
NCT01553838 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)
NCT04486755 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study
NCT01551576 ·Status: COMPLETED
-
Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy
NCT07075705 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
NCT00450411 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer
NCT00921193 ·Status: COMPLETED ·Phase: NA
-
Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy
NCT02790216 ·Status: UNKNOWN
-
MRI Guided Transurethral HIFU for Various Prostate Diseases
NCT03350529 ·Status: COMPLETED ·Phase: NA
-
Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate Cancer
NCT03817216 ·Status: WITHDRAWN ·Phase: NA
-
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
NCT05155046 ·Status: RECRUITING ·Phase: PHASE2